Novo A/S »

Arrivent Biopharma shares owned by Novo A/S

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Novo A/S

Quarter filed Position value Share count Share price at filing
2024-09-30 $35M 1.5M 23.50
2024-06-30 $28M 1.5M 18.55
2024-03-31 $19M 1.1M 17.86

More positions owned by Novo A/S

Vanguard Index Fds Total Stk Mkt (VTI)
Tempus Ai Cl A (TEM)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Edgewise Therapeutics (EWTX)
Corcept Therapeutics Incorporated (CORT)
Asml Holding N V N Y Registry Shs (ASML)
salesforce (CRM)
Vaxcyte (PCVX)
Mirum Pharmaceuticals (MIRM)
Miragen Therapeutics (VRDN)
Alibaba Group Hldg Sponsored Ads (BABA)
Insmed Com Par $.01 (INSM)
Crinetics Pharmaceuticals In (CRNX)
Cable One (CABO)
Arrivent Biopharma (AVBP)

View all positions for Novo A/S

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
Octagon Capital Advisors
Suvretta Capital Management
Sofinnova Ventures
Novo A/S
Sc China Holding
BlackRock
Vanguard Group
Cormorant Asset Management
Perceptive Advisors
Geode Capital Management
State Street Corporation
Woodline Partners
Charles Schwab Investment Management

View all funds holding Arrivent Biopharma